JAN Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Šios dienos apimtis	225 654
Vidutinė apimtis	318 446
Rinkos kapitalizacija	43.83M
EPS	$0 ( 2024-04-02 )
Kita pelno data	( $0 ) 2024-05-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.190
ATR14	$0.0370 (0.74%)

Insider Trading

Date	Person	Action	Amount	type
2023-01-05	Isaac Antonios	Buy	125 787	Common Stock
2023-01-05	Johnson Virland A	Buy	78 617	Common Stock
2021-05-24	Johnson Virland A	Sell	32 933	Common Shares
2020-11-03	Johnson Virland A	Sell	1 469	Common Stock
2021-02-05	Johnson Virland A	Sell	4 112	Common Stock

INSIDER POWER
100.00
Last 96 transactions
Buy: 2 390 604 \| Sell: 701 030

Tūris Koreliacija

Ilgas: -0.01 (neutral)

Trumpas: -0.79 (moderate negative)

Signal:(48.733) Neutral

Janone Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
SMMF	0.943
SHBI	0.939
FRBA	0.937
ORRF	0.936
MPB	0.933
SMBC	0.932
AMAL	0.93
PPBI	0.925
SPFI	0.925
CZNC	0.922

10 Labiausiai neigiamai susiję koreliacijos
TZPSU	-0.898
EBACU	-0.897
ECHO	-0.896
WMPN	-0.887
TCMD	-0.884
ARDX	-0.883
PFMT	-0.883
EXAS	-0.882
FWONK	-0.882
TZPS	-0.882

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Janone Inc Koreliacija - Valiuta/Žaliavos

-0.74
( moderate negative )

0.00
( neutral )

-0.56
( weak negative )

-0.22
( neutral )

0.67
( moderate )

Janone Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-1.50M (0.00 %)
EPS:	$-5.01

FY	2023
Pajamos:	$0
Bruto pelnas:	$-1.50M (0.00 %)
EPS:	$-5.01

FY	2022
Pajamos:	$39.61M
Bruto pelnas:	$7.62M (19.23 %)
EPS:	$1.140

FY	2021
Pajamos:	$40.02M
Bruto pelnas:	$8.87M (22.16 %)
EPS:	$-6.35

Financial Reports:

No articles found.

Janone Inc

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.